
Boehringer Ingelheim Animal Health USA Inc. is a leading innovator in animal health, providing vaccines, therapeutics, and parasite control products across the United States.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Boehringer Ingelheim Animal Health USA Inc. is likely focused on expanding its vaccine portfolio, enhancing digital solutions for veterinarians, and advancing sustainability initiatives in line with industry trends.
Introduction of new vaccines and therapeutics targeting emerging animal diseases
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Boehringer Ingelheim Animal Health USA Inc. delivers a comprehensive portfolio of animal health solutions, including some of the most widely used vaccines and therapeutics in the industry. The company operates research, manufacturing, and office sites across five states and Puerto Rico, ensuring coast-to-coast coverage and rapid distribution. As a subsidiary of the global Boehringer Ingelheim group, it benefits from advanced R&D capabilities and a strong focus on sustainability and innovation. Its products serve the needs of veterinarians, livestock producers, and pet owners, supporting animal well-being and public health.
St. Joseph, Missouri
1885
Private company